Correlation Between Q2 Holdings and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Q2 Holdings and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q2 Holdings and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Q2 Holdings and Lipocine, you can compare the effects of market volatilities on Q2 Holdings and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q2 Holdings with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q2 Holdings and Lipocine.

Diversification Opportunities for Q2 Holdings and Lipocine

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between QTWO and Lipocine is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Q2 Holdings and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Q2 Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q2 Holdings are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Q2 Holdings i.e., Q2 Holdings and Lipocine go up and down completely randomly.

Pair Corralation between Q2 Holdings and Lipocine

Given the investment horizon of 90 days Q2 Holdings is expected to generate 0.58 times more return on investment than Lipocine. However, Q2 Holdings is 1.71 times less risky than Lipocine. It trades about 0.34 of its potential returns per unit of risk. Lipocine is currently generating about -0.03 per unit of risk. If you would invest  8,450  in Q2 Holdings on August 27, 2024 and sell it today you would earn a total of  2,187  from holding Q2 Holdings or generate 25.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Q2 Holdings  vs.  Lipocine

 Performance 
       Timeline  
Q2 Holdings 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Q2 Holdings are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Q2 Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.
Lipocine 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Q2 Holdings and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Q2 Holdings and Lipocine

The main advantage of trading using opposite Q2 Holdings and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q2 Holdings position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind Q2 Holdings and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum